ASTRAZENECA PLC - ANNUAL GENERAL MEETING 2015 Results of Annual General Meeting held on 24 April 2015 AstraZeneca PLC announced the results of the voting at its Annual General Meeting today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 1 - 8 were passed as ordinary resolutions and resolutions 9 - 12 were passed as special resolutions. RESOLUTION VOTES FOR % OF VOTES % OF VOTES CAST TOTAL VOTES VOTES AGAINST VOTES IN TOTAL VOTES WITHHELD CAST CAST CAST AS A % OF ISSUED SHARE CAPITAL 1 To receive 877,576,463 99.67 2,921,581 0.33 880,498,044 69.68% 10,675,935 the Company's Accounts and the Reports of the Directors and Auditor for the year ended 31 December 2014 2 To confirm 886,527,613 99.66 2,986,602 0.34 889,514,215 70.40% 1,659,763 dividends 3 To re 876,751,815 98.61 12,397,571 1.39 889,149,386 70.37% 2,024,593 -appoint KPMG LLP, London as Auditor 4 To authorise 887,495,062 99.82 1,629,520 0.18 889,124,582 70.37% 2,049,398 the Directors to agree the remuneration of the Auditor 5a To re-elect 851,461,560 95.76 37,705,142 4.24 889,166,702 70.37% 2,007,277 Leif Johansson as a Director 5b To re-elect 888,590,119 99.95 426,241 0.05 889,016,360 70.36% 2,157,620 Pascal Soriot as a Director 5c To re-elect 885,602,969 99.62 3,374,856 0.38 888,977,825 70.36% 2,196,155 Marc Dunoyer as a Director 5d To elect 888,638,513 99.96 351,446 0.04 888,989,959 70.36% 2,184,021 Cori Bargmann as a Director 5e To re-elect 888,552,754 99.95 465,106 0.05 889,017,860 70.36% 2,156,120 Geneviève Berger as a Director 5f To re-elect 880,639,560 99.88 1,091,107 0.12 881,730,667 69.78% 9,443,312 Bruce Burlington as a Director 5g To re-elect 888,587,093 99.95 465,731 0.05 889,052,824 70.36% 2,121,156 Ann Cairns as a Director 5h To re-elect 876,994,757 99.46 4,732,631 0.54 881,727,388 69.78% 9,445,684 Graham Chipchase as a Director 5i To re-elect 880,585,784 99.87 1,137,760 0.13 881,723,544 69.78% 9,450,753 Jean -Philippe Courtois as a Director 5j To re-elect 855,335,488 99.27 6,300,712 0.73 861,636,200 68.19% 29,537,348 Rudy Markham as a Director 5k To re-elect 888,387,120 99.93 582,556 0.07 888,969,676 70.36% 2,204,192 Shriti Vadera as a Director 5l To re-elect 846,091,821 98.19 15,599,701 1.81 861,691,522 68.20% 29,482,025 Marcus Wallenberg as a Director 6 To approve 739,049,685 84.11 139,601,566 15.89 878,651,251 69.54% 12,522,725 the Annual Report on Remuneration for the year ended 31 December 2014 7 To authorise 859,081,444 97.36 23,307,997 2.64 882,389,441 69.83% 8,784,535 limited EU political donations 8 To authorise 808,454,239 91.14 78,551,101 8.86 887,005,340 70.20% 4,168,208 the Directors to allot shares 9 To authorise 875,263,416 98.61 12,347,679 1.39 887,611,095 70.25% 3,562,455 the Directors to disapply pre -emption rights 10 To authorise 876,130,644 98.54 13,023,264 1.46 889,153,908 70.37% 2,019,960 the Company to purchase its own shares 11 To reduce 778,280,838 87.53 110,881,255 12.47 889,162,093 70.37% 2,011,885 the notice period for general meetings 12 To adopt new 886,456,629 99.90 900,552 0.10 887,357,181 70.23% 3,813,971 Articles of Association Issued capital As at 22 April 2015, the number of issued shares of the Company was 1,263,544,938, ordinary shares, which was the total number of shares entitling the holders to attend and vote for or against all the resolutions at the AGM. In accordance with the Company's Articles of Association, on a poll every member present in person or by proxy has one vote for every share held. A C N Kemp Company Secretary 24 April 2015
Result of AGM
| Source: AstraZeneca PLC